Table Of Contents:

1 Introduction	7
1.1 Industry Definition and Research Scope	7
1.1.1 Industry Definition	7
1.1.2 Research Scope	9
1.2 Research Methodology	12
1.2.1 Overview of Market Research Methodology	12
1.2.2 Market Assumption	13
1.2.3 Secondary Data	13
1.2.4 Primary Data	13
1.2.5 Data Filtration and Model Design	14
1.2.6 Market Size/Share Estimation	15
1.2.7 Research Limitations	16
1.3 Executive Summary	17
2 Market Overview and Dynamics	19
2.1 Market Size and Forecast	19
2.1.1 Impact of COVID-19 on World Economy	22
2.1.2 Impact of COVID-19 on the Market	24
2.2 Major Growth Drivers	26
2.3 Market Restraints and Challenges	35
2.4 Emerging Opportunities and Market Trends	38
2.5 Porter’s Fiver Forces Analysis	42
3 Segmentation of North America Market by Offering	46
3.1 Market Overview by Offering	46
3.2 CRISPR Products	48
3.2.1 Kits & Enzymes	50
3.2.2 Databases & Libraries	51
3.2.3 Design Tools	52
3.2.4 Antibodies	53
3.2.5 CRISPR Plasmid & Vector	54
3.2.6 Other Products	55
3.3 CRISPR Services	56
3.3.1 gRNA Design & Vector Construction	58
3.3.2 Cell Line Engineering	59
3.3.3 Microbial Gene Editing	60
3.3.4 DNA Synthesis	61
3.3.5 Other Services	62
4 Segmentation of North America Market by Application	63
4.1 Market Overview by Application	63
4.2 Biomedical Research & Therapy	65
4.2.1 Gene Therapy	67
4.2.2 Drug Discovery	68
4.2.3 Diagnostics	69
4.2.4 Other Biomedical Applications	70
4.3 Agriculture	71
4.4 Industrial Use	72
4.5 Other Applications	73
5 Segmentation of North America Market by End User	74
5.1 Market Overview by End User	74
5.2 Pharmaceutical Companies	76
5.3 Biotechnology Companies	77
5.4 Academic Institutions & Research Centers	78
5.5 Other End Users	79
6 North America Market 2021-2031 by Country	80
6.1 Overview of North America Market	80
6.2 U.S.	83
6.3 Canada	86
6.4 Mexico	88
7 Competitive Landscape	89
7.1 Overview of Key Vendors	90
7.2 New Product Launch, Partnership, Investment, and M&A	94
7.3 Company Profiles	95
Abcam, Inc.	95
Agilent Technologies, Inc.	97
Applied StemCell, Inc.	98
Caribou Biosciences, Inc.	99
Cellecta, Inc.	100
CRISPR Therapeutics AG	101
Editas Medicine, Inc.	102
GeneCopoeia, Inc.	103
GeneScript Biotech Corporation	104
Horizon Discovery Group PLC	105
Integrated DNA Technologies, Inc.	106
Intellia Therapeutics Inc.	107
Lonza Group Ltd.	108
Merck KGaA	109
New England Biolabs, Inc.	110
Origene Technologies, Inc.	111
Rockland Immunochemicals, Inc.	112
Synthego Corporation	113
System Biosciences LLC	114
Takara Bio, Inc.	115
Thermo Fisher Scientific, Inc.	116
ToolGen, Inc.	117
RELATED REPORTS	118

List Of Tables:


Table 1.  Snapshot of North America CRISPR Gene Editing Market in Balanced Perspective, 2021-2031	18
Table 2. World Economic Outlook, 2021-2031	23
Table 3. Developing Roadmap of CRISPR Technology	27
Table 4. Private and Public Companies Investment in CRISPR Technology	28
Table 5. Comparison of CRISPR with Other Gene Editing Technologies	31
Table 6. World Health Spending by Region, $ bn, 2013-2020	34
Table 7.  Main Product Trends and Market Opportunities in North America CRISPR Gene Editing Market	38
Table 8. North America CRISPR Gene Editing Market by Offering, 2021-2031, $ mn	46
Table 9. North America CRISPR Gene Editing Market: CRISPR Products by Type, 2021-2031, $ mn	49
Table 10. North America CRISPR Gene Editing Market: Kits & Enzymes by Type, 2021-2031, $ mn	50
Table 11. North America CRISPR Gene Editing Market: CRISPR Services by Type, 2021-2031, $ mn	57
Table 12. North America CRISPR Gene Editing Market by Application, 2021-2031, $ mn	63
Table 13. North America CRISPR Gene Editing Market: Biomedical Research & Therapy by Type, 2021-2031, $ mn	66
Table 14. North America CRISPR Gene Editing Market by End User, 2021-2031, $ mn	74
Table 15. North America CRISPR Gene Editing Market by Country, 2021-2031, $ mn	81
Table 16. U.S. CRISPR Gene Editing Market by Offering, 2021-2031, $ mn	85
Table 17. U.S. CRISPR Gene Editing Market by Application, 2021-2031, $ mn	85
Table 18. U.S. CRISPR Gene Editing Market by End User, 2021-2031, $ mn	85
Table 19. Canada CRISPR Gene Editing Market by Offering, 2021-2031, $ mn	87
Table 20. Canada CRISPR Gene Editing Market by Application, 2021-2031, $ mn	87
Table 21. Canada CRISPR Gene Editing Market by End User, 2021-2031, $ mn	87
Table 22. Mexico CRISPR Gene Editing Market by Offering, 2021-2031, $ mn	89
Table 23. Mexico CRISPR Gene Editing Market by Application, 2021-2031, $ mn	89
Table 24. Mexico CRISPR Gene Editing Market by End User, 2021-2031, $ mn	89
Table 25. Breakdown of World Market by Key Vendor, 2021, %	92
Table 26. Abcam, Inc.: Company Snapshot	95
Table 27. Abcam, Inc.: Business Segmentation	96
Table 28. Abcam, Inc.: Product Portfolio	96

List Of Figures:


Figure 1. Research Method Flow Chart	12
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation	15
Figure 3. North America Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2021-2031	17
Figure 4. North America CRISPR Gene Editing Market, 2021-2031, $ mn	19
Figure 5. Categories of CRISPR-Cas Systems	20
Figure 6. Impact of COVID-19 on Business	24
Figure 7. Primary Drivers and Impact Factors of North America CRISPR Gene Editing Market	26
Figure 8.  Leading Causes of Death in the World, 2019-2020, million	32
Figure 9.  Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million	33
Figure 10. World Population 65 and Over, % of Total Population, 1950-2060	33
Figure 11. Primary Restraints and Impact Factors of North America CRISPR Gene Editing Market	35
Figure 12. Investment Opportunity Analysis	39
Figure 13. Porter’s Fiver Forces Analysis of North America CRISPR Gene Editing Market	42
Figure 14. Breakdown of North America CRISPR Gene Editing Market by Offering, 2021-2031, % of Revenue	47
Figure 15. North America Addressable Market Cap in 2022-2031 by Offering, Value ($ mn) and Share (%)	47
Figure 16. North America CRISPR Gene Editing Market by Offering: CRISPR Products, 2021-2031, $ mn	48
Figure 17. North America CRISPR Gene Editing Market by CRISPR Products: Kits & Enzymes, 2021-2031, $ mn	50
Figure 18. North America CRISPR Gene Editing Market by CRISPR Products: Databases & Libraries, 2021-2031, $ mn	51
Figure 19. North America CRISPR Gene Editing Market by CRISPR Products: Design Tools, 2021-2031, $ mn	52
Figure 20. North America CRISPR Gene Editing Market by CRISPR Products: Antibodies, 2021-2031, $ mn	53
Figure 21. North America CRISPR Gene Editing Market by CRISPR Products: CRISPR Plasmid & Vector, 2021-2031, $ mn	54
Figure 22. North America CRISPR Gene Editing Market by CRISPR Products: Other Products, 2021-2031, $ mn	55
Figure 23. North America CRISPR Gene Editing Market by Offering: CRISPR Services, 2021-2031, $ mn	56
Figure 24. North America CRISPR Gene Editing Market by CRISPR Services: gRNA Design & Vector Construction, 2021-2031, $ mn	58
Figure 25. North America CRISPR Gene Editing Market by CRISPR Services: Cell Line Engineering, 2021-2031, $ mn	59
Figure 26. North America CRISPR Gene Editing Market by CRISPR Services: Microbial Gene Editing, 2021-2031, $ mn	60
Figure 27. North America CRISPR Gene Editing Market by CRISPR Services: DNA Synthesis, 2021-2031, $ mn	61
Figure 28. North America CRISPR Gene Editing Market by CRISPR Services: Other Services, 2021-2031, $ mn	62
Figure 29. Breakdown of North America CRISPR Gene Editing Market by Application, 2021-2031, % of Sales Revenue	64
Figure 30. North America Addressable Market Cap in 2022-2031 by Application, Value ($ mn) and Share (%)	64
Figure 31. North America CRISPR Gene Editing Market by Application: Biomedical Research & Therapy, 2021-2031, $ mn	65
Figure 32. North America CRISPR Gene Editing Market by Biomedical Research & Therapy: Gene Therapy, 2021-2031, $ mn	67
Figure 33. North America CRISPR Gene Editing Market by Biomedical Research & Therapy: Drug Discovery, 2021-2031, $ mn	68
Figure 34. North America CRISPR Gene Editing Market by Biomedical Research & Therapy: Diagnostics, 2021-2031, $ mn	69
Figure 35. North America CRISPR Gene Editing Market by Biomedical Research & Therapy: Other Biomedical Applications, 2021-2031, $ mn	70
Figure 36. North America CRISPR Gene Editing Market by Application: Agriculture, 2021-2031, $ mn	71
Figure 37. North America CRISPR Gene Editing Market by Application: Industrial Use, 2021-2031, $ mn	72
Figure 38. North America CRISPR Gene Editing Market by Application: Other Applications, 2021-2031, $ mn	73
Figure 39. Breakdown of North America CRISPR Gene Editing Market by End User, 2021-2031, % of Sales Revenue	75
Figure 40. North America Addressable Market Cap in 2022-2031 by End User, Value ($ mn) and Share (%)	75
Figure 41. North America CRISPR Gene Editing Market by End User: Pharmaceutical Companies, 2021-2031, $ mn	76
Figure 42. North America CRISPR Gene Editing Market by End User: Biotechnology Companies, 2021-2031, $ mn	77
Figure 43. North America CRISPR Gene Editing Market by End User: Academic Institutions & Research Centers, 2021-2031, $ mn	78
Figure 44. North America CRISPR Gene Editing Market by End User: Other End Users, 2021-2031, $ mn	79
Figure 45. Breakdown of North America CRISPR Gene Editing Market by Country, 2021 and 2031, % of Revenue	81
Figure 46. Contribution to North America 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%)	82
Figure 47. U.S. CRISPR Gene Editing Market, 2021-2031, $ mn	84
Figure 48. Canada CRISPR Gene Editing Market, 2021-2031, $ mn	86
Figure 49.  CRISPR Gene Editing Market in Mexico, 2021-2031, $ mn	88
Figure 50. Growth Stage of North America CRISPR Gene Editing Industry over the Forecast Period	90

Selected Key Players: 
Abcam, Inc.
Agilent Technologies, Inc.
Applied StemCell, Inc.
Caribou Biosciences, Inc.
Cellecta, Inc.
CRISPR Therapeutics AG
Editas Medicine, Inc.
GeneCopoeia, Inc.
GeneScript Biotech Corporation
Horizon Discovery Group PLC
Integrated DNA Technologies, Inc.
Intellia Therapeutics Inc.
Lonza Group Ltd.
Merck KGaA
New England Biolabs, Inc.
Origene Technologies, Inc.
Rockland Immunochemicals, Inc.
Synthego Corporation
System Biosciences LLC
Takara Bio, Inc.
Thermo Fisher Scientific, Inc.
ToolGen, Inc. 
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)